# IM Recombinant Ricin Toxin Vaccine (RVEc) - 3-Dose Primary Series With Boost

> **NCT02385825** · PHASE1 · WITHDRAWN · sponsor: **U.S. Army Medical Research and Development Command**

## Conditions studied

- Ricin Poisoning

## Interventions

- **BIOLOGICAL:** RVEc

## Key facts

- **NCT ID:** NCT02385825
- **Lead sponsor:** U.S. Army Medical Research and Development Command
- **Sponsor class:** FED
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-04
- **Primary completion:** 2017-06
- **Final completion:** 2017-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** lack of funding
- **Last updated:** 2020-01-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02385825

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02385825, "IM Recombinant Ricin Toxin Vaccine (RVEc) - 3-Dose Primary Series With Boost". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT02385825. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*